What is the protocol for administering a nicardipine (Calcium Channel Blocker) drip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Administer Nicardipine Drip

Start nicardipine at 5 mg/hr IV infusion and titrate by increasing 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr until desired blood pressure is achieved. 1, 2, 3

Initial Setup and Preparation

Dilution Requirements

  • Single-dose vials (25 mg/10 mL) must be diluted before use: Mix each 25 mg vial with 240 mL of compatible IV fluid to achieve a final concentration of 0.1 mg/mL (250 mL total volume). 3
  • Flexible containers (0.1 mg/mL or 0.2 mg/mL) do not require dilution and can be used directly. 3

Compatible IV Fluids

  • Dextrose 5% in water 3
  • Normal saline (0.9% NaCl) 3
  • Dextrose 5% with 0.45% or 0.9% NaCl 3
  • Dextrose 5% with 40 mEq potassium 3

Incompatible Solutions (Do Not Use)

  • Sodium bicarbonate 5% 3
  • Lactated Ringer's solution 3

IV Access Considerations

  • Administer via central line or large peripheral vein to minimize venous irritation. 3
  • Avoid small veins (dorsum of hand or wrist) to reduce risk of thrombophlebitis. 3
  • Change peripheral infusion site every 12 hours to prevent phlebitis, which can occur after 14+ hours at a single site. 3, 4

Dosing Protocols by Clinical Scenario

For Acute Ischemic Stroke (Pre-thrombolytic)

If systolic BP >185 mmHg or diastolic BP >110 mmHg before rtPA:

  • Start at 5 mg/hr 1
  • Titrate by 2.5 mg/hr at 5-15 minute intervals 1
  • Maximum dose: 15 mg/hr 1
  • Once target BP achieved (<185/110 mmHg), reduce to 3 mg/hr for maintenance 1
  • If BP remains >185/110 mmHg despite maximum dose, do not administer rtPA 1

For Severe Hypertension (Non-stroke)

For gradual BP reduction:

  • Start at 5 mg/hr 2, 3
  • Increase by 2.5 mg/hr every 15 minutes 2, 3
  • Maximum: 15 mg/hr 2, 3

For rapid BP reduction:

  • Start at 5 mg/hr 2, 3
  • Increase by 2.5 mg/hr every 5 minutes 2, 3
  • Maximum: 15 mg/hr 2, 3

For Hypertensive Emergency in Pregnancy/Pre-eclampsia

  • Start at 5 mg/hr 1, 5
  • Titrate by 2.5 mg/hr every 5-15 minutes 1
  • Maximum: 15 mg/hr 1
  • Target BP: <160/105 mmHg 5

Conversion from Oral Nicardipine

Use equivalent IV infusion rates: 3

  • Oral 20 mg TID → IV 0.5 mg/hr
  • Oral 30 mg TID → IV 1.2 mg/hr
  • Oral 40 mg TID → IV 2.2 mg/hr

Monitoring Requirements

During Titration

  • Continuous blood pressure and heart rate monitoring during active titration 2, 3
  • Monitor for hypotension (>10% decrease) or tachycardia (>20 bpm increase) 3, 6

Post-thrombolytic Patients (Stroke)

  • BP every 15 minutes for first 2 hours 1, 2
  • BP every 30 minutes for next 6 hours 1, 2
  • BP every hour for subsequent 16 hours 1, 2

General Monitoring

  • Inspect IV site frequently for signs of phlebitis or extravasation 3
  • Monitor for headache, flushing, and reflex tachycardia 1, 3

Pharmacokinetics

  • Onset of action: 5-15 minutes 2, 5
  • Duration after discontinuation: 30-40 minutes (50% offset) 2, 5, 4
  • Time to 50% of maximum effect: ~45 minutes with constant infusion 3

Management of Adverse Effects

If Hypotension or Excessive Tachycardia Occurs

  • Immediately discontinue infusion 3
  • After stabilization, may restart at lower dose (3-5 mg/hr) 3

Common Side Effects

  • Headache (13% incidence) 3, 4
  • Hypotension (5%) 3
  • Tachycardia (4%) - typically increases heart rate by ~10 bpm 3, 4
  • Nausea/vomiting (4%) 3
  • Flushing 1, 4

Critical Contraindications and Precautions

  • Absolute contraindication: Advanced aortic stenosis 3
  • Not a beta-blocker substitute: Provides no protection against abrupt beta-blocker withdrawal 3
  • Use caution in patients with heart failure, hepatic impairment, or renal dysfunction 3
  • Avoid intraarterial administration or extravasation 3

Special Populations

Pregnancy

  • Considered safe and effective for hypertensive emergencies in pregnancy 5
  • Breastfeeding not recommended while on nicardipine 3

Pediatrics

  • Safety and efficacy not established in patients <18 years 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nicardipine Infusion Titration Protocol for Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intravenous nicardipine for the treatment of severe hypertension.

The American journal of medicine, 1988

Guideline

Nicardipine Drip Titration Protocol for Acute Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.